CD8A and cancer: Indeed, initial studies suggested that applying WBH at 41.8-42.2°C in patients with advance cancer, led to a reduction in CD4+ T-cells, accompanied by an increase in NK cells and γδ-T cells, which resulted in a decrease in the CD4+/CD8+ ratio (97).